Small company makes big advances in fighting antibiotic-resistant diseases and cancer

Chelation Partners’ approach to fighting antibiotic-resistant diseases is a novel one: cutting off their supply of iron. Without iron, bacteria have a tough time growing, and they’re more vulnerable to the effects of antibiotics. What’s more, Chelation Partners has discovered this tactic could also be applied to the fight against cancer. Cancer cells seem to be more sensitive to lower iron levels than other cells in the body, so reducing the availability of the metal might restrict the growth of cancer and boost the effectiveness of chemotherapy and radiation treatment.

London-based company sees the value in research partnership

Supported by Mitacs, the partnership between Trojan Technologies and Western University has grown considerably over the last four years. Since 2010, Trojan has invested a significant portion of its research budget to hire Mitacs interns, an amount that has been more than matched through Mitacs funding for a total of $1.5 million in R&D spending.

Currently, the company is building a three-year research program that will further expand their collaborations to include research on opaque fluids, as well as UV treatment of ballast water, waste water, and drinking water. 

Mitacs Award winner interview: Ricardo Jota, University of Toronto

Teledyne DALSA leverages Mitacs grants for high-tech success

Teledyne DALSA is a Canadian manufacturer of specialized electronic imaging components with offices in Montreal. The company is a leading manufacturer of heat (infrared) sensors for use in satellites, surveillance and medical applications — fields which attract extensive research and development investment from both government and industry.

Innovation that goes bone-deep at University of Alberta

Researchers like Yang Yang, a Mitacs Elevate postdoctoral fellow in the Pharmaceutical Orthopaedic Research lab at the University of Alberta, are tackling the problem head-on by developing new treatments for the disease. In partnership with Osteo-Metabolix Pharmaceuticals Inc., Yang has created a new drug that does a better job of healing broken bones.

Taking innovative crowdsourcing to the next level

When Calgary-based Chaordix, a pioneer in the crowdsourcing space, was looking to gain further insight into market research intelligence and analytics, they turned to Mitacs.  We connected the company with intern Khobaib Zaamout, a PhD student in the department of Information and Communication Technology at the University of Calgary.

2014 Mitacs Awards Reception celebrates emerging Canadian researchers

Winners at a glance

SideStix Ventures pairs with Mitacs Accelerate for evidence-based success

PhD student Megan MacGillivray from UBC's Department of Rehabilitation Sciences partnered with SideStix Ventures Inc. to evaluate the biomechanics of their high-performance forearm crutch.

Watch founder Sarah Doherty and intern Megan explain their innovation.

Boosting innovation in the ICT industry

To meet its clients’ needs and an increasing demand for high-performance Automatic Speech Recognition (ASR) solutions, Nuance established a long-term research project that focuses on refining these products for mobile applications.

Refining innovative technologies

With the support of Pierre des Lierres, Business Development Director at Mitacs, the company obtained the financial support of Mitacs Accelerate Quebec and connected with Iban Harlouchet and Professor Pierre Lafaye de Micheaux from the Department of Mathematics and Statistics at Université de Montréal. Iban undertook research at Odotech to optimize algorithms of the e-nose sensors that analyze olfactory emissions.

Pages